Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for XNCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 74.33M
March 31, 2026 74.06M
December 31, 2025 71.87M
September 30, 2025 71.34M
June 30, 2025 71.30M
March 31, 2025 71.14M
December 31, 2024 70.26M
September 30, 2024 69.96M
June 30, 2024 61.77M
March 31, 2024 61.63M
December 31, 2023 61.00M
September 30, 2023 60.67M
June 30, 2023 60.60M
March 31, 2023 60.38M
December 31, 2022 60.00M
September 30, 2022 59.77M
June 30, 2022 59.68M
March 31, 2022 59.53M
December 31, 2021 59.36M
September 30, 2021 58.45M
June 30, 2021 58.32M
March 31, 2021 58.22M
December 31, 2020 57.87M
September 30, 2020 57.37M
June 30, 2020 57.21M
Date Value
March 31, 2020 57.00M
December 31, 2019 56.90M
September 30, 2019 56.71M
June 30, 2019 56.53M
March 31, 2019 56.35M
December 31, 2018 56.28M
September 30, 2018 56.21M
June 30, 2018 55.82M
March 31, 2018 55.62M
December 31, 2017 47.00M
September 30, 2017 46.96M
June 30, 2017 46.85M
March 31, 2017 46.69M
December 31, 2016 46.57M
September 30, 2016 41.14M
June 30, 2016 40.94M
March 31, 2016 40.74M
December 31, 2015 40.55M
September 30, 2015 40.48M
June 30, 2015 40.46M
March 31, 2015 40.36M
December 31, 2014 31.43M
September 30, 2014 31.40M
June 30, 2014 31.39M
March 31, 2014 31.36M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
UroGen Pharma Ltd. 48.87M
MeiraGTx Holdings Plc 94.19M
Regeneron Pharmaceuticals, Inc. 103.40M
Ironwood Pharmaceuticals, Inc. 165.24M
MacroGenics, Inc. 63.65M